- Home
- Equities - Stocks - Shares
- Company Press Releases
- Update Regarding Funding of The Company
Update regarding funding of the company
23 Mar 2023 20:39 CET
Issuer
SoftOx Solutions AS
The company has explored several options, including interest for a private
placement, but is still in need of new capital to fund the company's operations
and liabilities. It will continue its efforts to solve the short- and long-term
liquidity needs, which may involve a wider capital raising, divestment of assets
or strategy changes. The company will update the market once it has specific
news.
For further information, please contact:
Geir Almås, Executive Chairman of SoftOx Solutions AS
Christian Harstad, Interim CEO of SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and
clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of
reducing the spread of infection and emergence of antimicrobial resistance. For
more information on SoftOx, visit www.soft-ox.com
More information:
Access the news on Oslo Bors NewsWeb site
Source
SoftOx Solutions AS
Provider
Oslo Børs Newspoint
Company Name
SOFTOX SOLUTIONS
ISIN
NO0010811961
Symbol
SOFTX
Market
Euronext Growth